Mad 1 Activators
The Mad1 activators represent a diverse group of compounds that modulate the activity of Mad1, a transcription factor crucial for various cellular processes. These chemicals exert their effects through distinct biochemical pathways, orchestrating a finely tuned regulatory network. Retinoic acid, for instance, engages the retinoic acid receptor (RAR)/retinoid X receptor (RXR) pathway, leading to enhanced Mad1 transcription. This activation is pivotal for cellular differentiation and development, as RAR/RXR signaling plays a central role in coordinating gene expression patterns. Resveratrol, on the other hand, operates through the sirtuin 1 (SIRT1)/AMP-activated protein kinase (AMPK) pathway. By activating SIRT1, resveratrol facilitates the deacetylation of Mad1, promoting its nuclear translocation and transcriptional activity. This mechanism highlights the intricate interplay between metabolic pathways and transcriptional regulation in controlling Mad1 function.
Prostaglandin E2 (PGE2) utilizes the EP4/cAMP/protein kinase A (PKA) pathway to activate Mad1. Binding to EP4 receptors triggers a cascade of events leading to increased cAMP levels and subsequent PKA activation. This phosphorylation event on Mad1 is integral for its activation and involvement in various cellular processes. Collectively, these Mad1 activators exemplify the intricate web of signaling pathways that converge on Mad1, underscoring the multifaceted nature of cellular regulation. Understanding the specific pathways influenced by these chemicals provides valuable insights into the molecular mechanisms orchestrating Mad1 activation, paving the way for targeted interventions in cellular processes
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a derivative of vitamin A, activates Mad1 by influencing the RAR/RXR pathway. It binds to retinoic acid receptors, leading to enhanced Mad1 transcription and subsequent activation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates Mad1 through the SIRT1/AMPK pathway. It functions as a SIRT1 activator, promoting deacetylation of Mad1 and facilitating its translocation to the nucleus, where it exerts its transcriptional activity. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) activates Mad1 by modulating the EP4/cAMP/PKA pathway. PGE2 binds to EP4 receptors, leading to increased cAMP levels and subsequent activation of PKA, which phosphorylates and activates Mad1. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB-431542 indirectly activates Mad1 by inhibiting TGF-β/Smad signaling. It blocks the activin type I receptor, preventing the inhibitory Smad pathway's activation and allowing Mad1 to function uninhibited. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 activates Mad1 by inhibiting the PI3K/AKT pathway. It hinders AKT activation, relieving the inhibitory phosphorylation on Mad1 and promoting its transcriptional activity. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
C646 activates Mad1 by inhibiting the p300/CBP histone acetyltransferase. It specifically targets the histone acetyltransferase activity of p300/CBP, enhancing Mad1 acetylation and promoting its activation. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 activates Mad1 by inhibiting BRD4-mediated transcriptional repression. It competitively binds to bromodomain 1 of BRD4, preventing its association with chromatin and allowing Mad1 to exert its transcriptional function. | ||||||
AZD8055 | 1009298-09-2 | sc-364424 sc-364424A | 10 mg 50 mg | $163.00 $352.00 | 12 | |
AZD8055 activates Mad1 by inhibiting the mTOR pathway. It targets both mTORC1 and mTORC2, disrupting downstream signaling cascades and promoting Mad1 activation. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A769662 activates Mad1 by activating AMPK. It functions as an AMP mimetic, promoting AMPK phosphorylation and subsequent activation, which indirectly enhances Mad1 activity through AMPK-mediated signaling. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A activates Mad1 by inhibiting histone deacetylases (HDACs). It specifically targets class I and II HDACs, promoting histone acetylation and facilitating Mad1 transcriptional activity. | ||||||